Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D01ICU
|
||||
Former ID |
DNAP001333
|
||||
Drug Name |
Conjugated estrogens b
|
||||
Synonyms |
Enjuvia (TN)
|
||||
Indication | Hormone replacement therapy [ICD9: V07.4; ICD10:Z79.890] | Approved | [551871] | ||
Target and Pathway | |||||
Target(s) | Estrogen receptor | Target Info | Modulator | [533439], [536361] | |
Pathway Interaction Database | Regulation of nuclear SMAD2/3 signaling | ||||
Signaling events mediated by HDAC Class II | |||||
Plasma membrane estrogen receptor signaling | |||||
LKB1 signaling events | |||||
Regulation of Telomerase | |||||
ATF-2 transcription factor network | |||||
AP-1 transcription factor network | |||||
FOXM1 transcription factor network | |||||
Validated nuclear estrogen receptor alpha network | |||||
Signaling mediated by p38-alpha and p38-beta | |||||
FOXA1 transcription factor network | |||||
References | |||||
Ref 533439 | Effect of MK-486 alone on Parkinsonism; studies on the clinical symptoms and catecholamine concentrations in the blood, urine and cerebrospinal fluid. No To Shinkei. 1977 Feb;29(2):205-13. | ||||
Ref 536361 | Natural products as sources of new drugs over the last 25 years. J Nat Prod. 2007 Mar;70(3):461-77. Epub 2007 Feb 20. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.